NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/04/2025
Back to search
Official data from USPTO
ART-PLAN ADAPTATIVE RADIOTHERAPY TREATMENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
ART-PLAN ADAPTATIVE RADIOTHERAPY TREATMENT
ST13
US500000079278161Class
9, 42
Filing
79278161
Registration
6648717
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
04/05/2025
Classification
Registered
Trademark type
Word
Nice classes
9, 42
Filing date
11/26/2019
Registration date
02/22/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/22/2022
Last transaction
04/05/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
F-75014 Paris, FR
Examiner
PEREZ, STEVEN
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
THERAPANACEA
Representatives
Jess M. Collen Collen IP Intellectual Property Law, P.C.
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Image recording apparatus; digital recording mediablank optical discs; recorded or downloadable software for the medical fieldan AI-poweredradiotherapy planning software that streamlines and standardizes the cancer treatment planning; recorded or downloadable software applications for patient information and supportfor management of patient records; recorded or downloadable software for use in the field of cancer therapy for processing and displaying multi modality images to prepare treatment; recorded or downloadable software using artificial intelligence for facilitating precision radiotherapy treatment of cancer
Class 42
Scientific and medical research; research and development of new therapies for cancer treatment; scientific research in the medical fieldin particular relating to cancer treatment; online software design using artificial intelligence in the field of cancer treatment aimed at developing precision radiation therapy for improving the clinical effects of treatment; software as a service (SaaS) featuring software for the medical fieldan AI-poweredweb-based radiotherapy planning software that streamlines and standardizes the cancer treatment planning; software as a service (SaaS) featuring software for use in database managementfor medical use; cloud computing featuring software for use in database managementfor medical use; information technology (IT) consultancy; hosting of servers; electronic data storage
Publications
History of USPTO decisions and trademark events.
49 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/29/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/22/2022
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
07/26/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
07/26/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/22/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/19/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/22/2022
GPNX
NOTIFICATION PROCESSED BY IB
12/12/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/07/2021
PUBO
PUBLISHED FOR OPPOSITION
12/07/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/17/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/17/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/08/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/08/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/24/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/07/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/07/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/07/2021
GNRT
NON-FINAL ACTION E-MAILED
06/07/2021
CNRT
NON-FINAL ACTION WRITTEN
06/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/30/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/29/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/29/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/12/2021
GNRT
NON-FINAL ACTION E-MAILED
01/12/2021
CNRT
NON-FINAL ACTION WRITTEN
01/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/21/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/21/2020
ALIE
ASSIGNED TO LIE
12/18/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/23/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/27/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/27/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/27/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/27/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/27/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/27/2020
RFNT
REFUSAL PROCESSED BY IB
04/17/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/31/2020
RFRR
REFUSAL PROCESSED BY MPU
03/31/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/16/2020
CNRT
NON-FINAL ACTION WRITTEN
03/15/2020
DOCK
ASSIGNED TO EXAMINER
02/28/2020
MAFR
APPLICATION FILING RECEIPT MAILED
02/14/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/10/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/06/2020
Continuous trademark protection
Get notified about every new filing that threatens ART-PLAN ADAPTATIVE RADIOTHERAPY TREATMENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.